Thursday, September 18, 2014 Last update: 6:33 AM - All Company Technology News Since 1996

Array BioPharma To Report Financial Results For The Third Quarter Of Fiscal 2014 On April 29, 2014

Companies mentioned in this article: Array BioPharma Inc.

BOULDER, Colo., April 23, 2014 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for the third quarter of fiscal 2014 and hold a conference call to discuss those results on Tuesday, April 29, 2014. Ron Squarer, Chief Executive Officer and Michael Carruthers, Chief Financial Officer will lead the call.

    Conference Call Information

    Date:                                  Tuesday, April 29, 2014

    Time:                                  9:00 a.m. eastern time

    Toll-Free:                             (800) 708-4540

    Toll:                                  (847) 619-6397

    Pass Code:                                                              36946658

    Webcast, including Replay and Conference Call Slides:

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Seven Phase 3 or pivotal studies are already in progress, or are planned to begin, within the next year. These programs include the wholly-owned hematology drug, filanesib for multiple myeloma and two partnered cancer drugs, selumetinib (AstraZeneca) and binimetinib (Novartis). For more information on Array, please go to

    CONTACT:               Tricia Haugeto

                           Array BioPharma Inc.

                           (303) 386-1193


Logo -

SOURCE Array BioPharma Inc.